Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Competition is stiff between domestic and international companies to gain a large share for the diabetes market that is growing at a phenomenal rate
With the number of patients spiralling up, India is becoming the ?diabetes capital? of the world. This growth will propel pharma companies? future as well. According to research reports, total anti-diabetic market in India will grow at a compound annual growth rate (CAGR) of 13% over 2009-2019 to Rs7,348.9 crore from Rs2,127.3 crore.
http://www.moneylife.in/article/pha...nding-diabetes-therapeutics-market/21708.html
With the number of patients spiralling up, India is becoming the ?diabetes capital? of the world. This growth will propel pharma companies? future as well. According to research reports, total anti-diabetic market in India will grow at a compound annual growth rate (CAGR) of 13% over 2009-2019 to Rs7,348.9 crore from Rs2,127.3 crore.
http://www.moneylife.in/article/pha...nding-diabetes-therapeutics-market/21708.html